- Home
- TAK vs STT Comparison
TAK vs STT Comparison
Compare TAK & STT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TAK | STT |
|---|---|---|
| Founded | 1781 | 1792 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.6B | 50.6B |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TAK | STT |
|---|---|---|
| Price | $18.70 | $193.84 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $148.86 |
| AVG Volume (30 Days) | ★ 2.5M | 1.2M |
| Earning Date | 05-13-2026 | 04-17-2026 |
| Dividend Yield | ★ 3.24% | 2.23% |
| EPS Growth | N/A | ★ 14.49 |
| EPS | N/A | ★ 6.14 |
| Revenue | N/A | ★ $13,944,000,000.00 |
| Revenue This Year | $0.16 | $7.66 |
| Revenue Next Year | $1.22 | $3.87 |
| P/E Ratio | $41.25 | ★ $30.96 |
| Revenue Growth | N/A | ★ 7.26 |
| 52 Week Low | $12.99 | $104.64 |
| 52 Week High | $18.90 | $195.93 |
Technical Indicators
Market Signals| Indicator | TAK | STT |
|---|---|---|
| Relative Strength Index (RSI) | 68.29 | 59.42 |
| Support Level | $16.29 | $182.96 |
| Resistance Level | $18.86 | $194.54 |
| Average True Range (ATR) | 0.21 | 4.01 |
| MACD | 0.02 | -0.31 |
| Stochastic Oscillator | 90.68 | 81.34 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
About STT State Street Corporation
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $54 trillion in assets under custody and administration, and $5.7 trillion in assets under management, as of Dec. 31, 2025, State Street operates globally in more than 100 geographic markets and employs about 51,500 worldwide.